How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson’s disease?

Taylor and Francis Group, Expert Review of Neurotherapeutics, 2(23), p. 107-122, 2023

Journal article published in 2023 by Abhishek Lenka, Joseph Jankovic

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by